Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
Clinical trial NCT05034393 · COMPLETED
Trial details
- NCT number
- NCT05034393
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-04
- Primary completion
- 2023-02-27
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.